Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis

Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis

Abstract Background The prognosis of patients with combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma (CHC) is usually poor, and effective adjuvant therapy is missing making it important to investigate whether these patients may benefit from adjuvant transarterial chemoembolizatio...

Full description

Bibliographic Details
Main Authors: Wei-Ren Liu, Meng-Xin Tian, Chen-Yang Tao, Zheng Tang, Yu-Fu Zhou, Shu-Shu Song, Xi-Fei Jiang, Han Wang, Pei-Yun Zhou, Wei-Feng Qu, Yuan Fang, Zhen-Bin Ding, Jian Zhou, Jia Fan, Ying-Hong Shi
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Cancer
Subjects:
Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Transarterial chemoembolization
Overall survival
Disease-free survival
Propensity score matching analysis
Online Access:http://link.springer.com/article/10.1186/s12885-020-07138-z

Internet

http://link.springer.com/article/10.1186/s12885-020-07138-z

Similar Items